Related Experiment Video
Updated: Jul 11, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Hyperthyroidism in thyroid carcinoma originating in struma ovarii
Juliana Bezerra Mesquita1, Rosa Paula M Biscolla2
1Liga Norte Riograndense Contra o Cancer, Natal, Brazil.
Endocrinology, Diabetes & Metabolism Case Reports
|October 3, 2024
Summary
Thyroid carcinoma in Struma Ovarii is rare. This case highlights the importance of evaluating thyroid function and using radioiodine therapy after total thyroidectomy for remission in high-risk patients.
Area of Science:
- Gynecology
- Endocrinology
- Oncology
Background:
- Thyroid carcinoma originating in Struma Ovarii (SO) is an exceptionally rare ectopic malignancy.
- It accounts for approximately 0.01% of all ovarian malignancies and is infrequently associated with hyperthyroidism.
Purpose of the Study:
- To report a rare case of papillary thyroid carcinoma arising in Struma Ovarii.
- To emphasize the diagnostic and therapeutic challenges, including the role of thyroid function evaluation and radioiodine therapy (RIT).
Main Methods:
- A 44-year-old patient presented with pelvic pain and was diagnosed with a complex ovarian mass.
- Initial surgery revealed a borderline serous tumor and papillary thyroid carcinoma. Subsequent evaluations included thyroid function tests and TRAb assays.
- The patient underwent total thyroidectomy and radioiodine therapy (RIT).
Main Results:
- Histopathological examination confirmed papillary thyroid carcinoma within the Struma Ovarii, extending to the uterine serosa and right adnexa.
- The patient initially showed hyperthyroidism, which normalized after ovarian surgery, but TRAb remained positive.
- Following total thyroidectomy and RIT, the TRAb test became negative, with no tumor recurrence during 3 years of follow-up.
Conclusions:
- Thyroid function evaluation is crucial in patients diagnosed with Struma Ovarii.
- Radioiodine therapy after total thyroidectomy may be essential for achieving disease remission in high-risk cases of thyroid carcinoma originating in SO.
Related Concept Videos
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

